Analysts expect Kazia Therapeutics Ltd to report revenue of 0.00 for 2023, against a range of 0.00 to 0.00. The most recent reported year, 2026, came in at 349,330.00, a 22.2% miss against the 448,750.46 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 17,220.00 | - | - | 38,810.00 | 349,330.00 | ||||
| High Estimate | 11,575.39 | 0.00 | 102,348.64 | 47,665.75 | 470,458.76 | ||||
| Low Estimate | 10,228.07 | 0.00 | 90,616.36 | 42,565.61 | 427,042.16 | ||||
| Consensus Estimate | 10,901.73 | 0.00 | 96,482.50 | 45,115.68 | 448,750.46 |
Analysts expect Kazia Therapeutics Ltd to report earnings per share of -31.81 for 2024, against a range of -34.23 to -29.39. The most recent reported year, 2026, came in at -1.58, a 12.9% miss against the -1.40 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -64.08 | -36.25 | - | -1.23 | -1.58 | - | |||
| High Estimate | -57.54 | -35.78 | -29.39 | -0.01 | -1.28 | -1.49 | |||
| Low Estimate | -69.44 | -38.28 | -34.23 | -0.01 | -1.52 | -1.59 | |||
| Consensus Estimate | -63.49 | -37.03 | -31.81 | -0.01 | -1.40 | -1.54 |
Pull Wall Street consensus for Kazia Therapeutics Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KZIA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KZIA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KZIA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();